Safety and Efficacy of Cabazitaxel in the Docetaxel-Treated Patients with Hormone-Refractory Prostate Cancer

Prostate cancer (PC) is one of the most common cancers and is a leading cause of death. Its initial growth is dependent on androgens; most patients show an initial response to hormonal therapy but will experience disease progression when PC becomes resistant to castration. In 2004, two key randomize...

Descripción completa

Detalles Bibliográficos
Autores principales: Calcagno, Fabien, Nguyen, Thierry, Dobi, Erion, Villanueva, Cristian, Curtit, Elsa, Kim, Stefano, Montcuquet, Philippe, Kleinclauss, François, Pivot, Xavier, Thiery-Vuillemin, Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547543/
https://www.ncbi.nlm.nih.gov/pubmed/23362372
http://dx.doi.org/10.4137/CMO.S7256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547543/
https://www.ncbi.nlm.nih.gov/pubmed/23362372
http://dx.doi.org/10.4137/CMO.S7256

Ejemplares similares